AVALO THERAPEUTICS, INC. Disposal Group, Including Discontinued Operation, Liabilities, Current
AVALO THERAPEUTICS, INC. (AVTX) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2022-03-02
- 2021-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2021-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $10.00K.
- 2021-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $98.00K.
- 2021-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $209.00K.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current | Disposal Group, Including Discontinued Operation, Liabilities, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-02 | |
| 2021-09-30 | $10.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $98.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $209.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.34M 10-K · filed 2022-03-02 | $1.34M 10-K · filed 2021-03-08 |
| 2020-09-30 | $5.83M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $5.55M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $6.41M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.89M 10-K · filed 2021-03-08 | |
| 2018-12-31 | $7.55M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |